Camber Launches Lidocaine HCl Single-Dose & Multi-Dose Injections

Camber Pharmaceuticals is excited to introduce Lidocaine HCl Injection, USP, in Single-Dose and Multi-Dose Vials. Featuring 1% and 2% concentrations, this versatile product is available in various vial and pack sizes to meet diverse healthcare needs.
Click below to learn more:
Single-Dose Vials: https://www.camberpharma.com/products/lidocaine-sdv/
Multi-Dose Vials: https://www.camberpharma.com/products/lidocaine-mdv/
Camber Pharmaceuticals, a fully integrated pharmaceutical company, is dedicated to delivering high-quality generic medications that enhance lives through cost-effective healthcare solutions. As a subsidiary of Hetero, a global leader in active pharmaceutical ingredients (APIs) and finished dosage manufacturing based in Hyderabad, India, Camber leverages its expertise to ensure access to affordable, reliable pharmaceuticals for consumers worldwide.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection